Promising Kidney Drug Fails in Large Clinical Trial

1) Suloxdexide is no better than placebo at preventing kidney failure or reducing urinary protein excretion in diabetes patients with kidney failure. 2) Kidney disease due to diabetes is the most common cause of kidney failure in developed countries. 3) The prevalence of type 2 diabetes is expected to double by 2030. Kidney disease cases are sure to rise in parallel.

Read the whole article on Newswise - Scinews

More from Newswise - Scinews